Long-term evolution of direct healthcare costs for inflammatory bowel diseases: a population-based study (2006–2015)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term evolution of direct healthcare costs for inflammatory bowel diseases: a population-based study (2006–2015)

Published:2019-03-24 Issue:4 Volume:54 Page:419-426
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Kim Jung-Wook¹^ORCID,Lee Chang Kyun¹^ORCID,Lee Jung Kuk²,Jeong Su Jin³,Oh Shin Ju¹,Moon Jung Rock¹,Kim Hyun-Soo⁴,Kim Hyo Jong¹

Affiliation:

1. Center for Crohn’s and Colitis, Department of Gastroenterology, Kyung Hee University College of Medicine, Seoul, Republic of Korea;

2. Department of Biostatistics, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea;

3. Department of Statistics Support, Medical Science Research Institute, Kyung Hee University Medical Center, Seoul, Republic of Korea;

4. Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea

Funder

Kyung Hee University

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2019.1591498

Reference37 articles.

1. Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study

2. An Update on the Epidemiology of Inflammatory Bowel Disease in Asia

3. The global burden of IBD: from 2015 to 2025

4. Inflammatory Bowel Disease: A Canadian Burden of Illness Review

5. Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study;Intestinal Research;2024-05-22

2. The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs;Journal of the Canadian Association of Gastroenterology;2023-09-01

3. Increasing healthcare costs in inflammatory bowel disease 2007–2020 in Sweden;Alimentary Pharmacology & Therapeutics;2023-08-18

4. Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis;International Journal of Colorectal Disease;2023-06-23

5. Nutraceuticals in the Treatment of Inflammatory Bowel Disease: How the Panorama has Changed in the Last Decade?;Current Medicinal Chemistry;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3